390 related articles for article (PubMed ID: 9862710)
1. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.
Alexander J; Coombs GH; Mottram JC
J Immunol; 1998 Dec; 161(12):6794-801. PubMed ID: 9862710
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models.
Saravia NG; Escorcia B; Osorio Y; Valderrama L; Brooks D; Arteaga L; Coombs G; Mottram J; Travi BL
Vaccine; 2006 May; 24(19):4247-59. PubMed ID: 16216395
[TBL] [Abstract][Full Text] [Related]
3. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
Zadeh-Vakili A; Taheri T; Taslimi Y; Doustdari F; Salmanian AH; Rafati S
Vaccine; 2004 May; 22(15-16):1930-40. PubMed ID: 15121305
[TBL] [Abstract][Full Text] [Related]
4. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses.
Pollock KG; McNeil KS; Mottram JC; Lyons RE; Brewer JM; Scott P; Coombs GH; Alexander J
J Immunol; 2003 Feb; 170(4):1746-53. PubMed ID: 12574338
[TBL] [Abstract][Full Text] [Related]
5. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
6. Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis.
Alves CR; Benévolo-De-Andrade TC; Alves JL; Pirmez C
Parasite Immunol; 2004 Mar; 26(3):127-35. PubMed ID: 15279623
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the natural inhibitor of cysteine peptidases in Leishmania mexicana leads to reduced virulence and a Th1 response.
Bryson K; Besteiro S; McGachy HA; Coombs GH; Mottram JC; Alexander J
Infect Immun; 2009 Jul; 77(7):2971-8. PubMed ID: 19433541
[TBL] [Abstract][Full Text] [Related]
9. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
Stamm LM; Räisänen-Sokolowski A; Okano M; Russell ME; David JR; Satoskar AR
J Immunol; 1998 Dec; 161(11):6180-8. PubMed ID: 9834104
[TBL] [Abstract][Full Text] [Related]
10. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice.
Daneshvar H; Hagan P; Phillips RS
Parasite Immunol; 2003; 25(11-12):589-96. PubMed ID: 15053780
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
12. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity.
Buxbaum LU; Denise H; Coombs GH; Alexander J; Mottram JC; Scott P
J Immunol; 2003 Oct; 171(7):3711-7. PubMed ID: 14500670
[TBL] [Abstract][Full Text] [Related]
13. Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 mice.
Doroud D; Zahedifard F; Vatanara A; Najafabadi AR; Rafati S
Parasite Immunol; 2011 Jun; 33(6):335-48. PubMed ID: 21410716
[TBL] [Abstract][Full Text] [Related]
14. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
16. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
17. Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection.
Buxbaum LU
Parasite Immunol; 2010 Feb; 32(2):153-60. PubMed ID: 20070829
[TBL] [Abstract][Full Text] [Related]
18. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.
Daneshvar H; Coombs GH; Hagan P; Phillips RS
J Infect Dis; 2003 May; 187(10):1662-8. PubMed ID: 12721947
[TBL] [Abstract][Full Text] [Related]
19. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
[TBL] [Abstract][Full Text] [Related]
20. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.
Krishnan L; Guilbert LJ; Wegmann TG; Belosevic M; Mosmann TR
J Immunol; 1996 Jan; 156(2):653-62. PubMed ID: 8543817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
